欧美丰满老熟妇AAAA片,AA片在线观看视频在线播放

產(chǎn)品編號	BIO0875SM
英文名稱	Anti-human NaPi2b / SLC34A2 (Lifastuzumab vedotin Biosimilar)
中文名稱
抗體來源
克隆類型	Monoclonal
交叉反應(yīng)	Human
產(chǎn)品應(yīng)用	not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
理論分子量	145 kDa
檢測分子量
性狀	Lyophilized
亞型	Human IgG1
純化方法	Protein A
保存條件	For long term storage, the produce should be stored at -20°C or lower.
注意事項	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed	PubMed
產(chǎn)品介紹
產(chǎn)品圖片	Human NaPi2b HEK293 Cell Line were stained with Anti-NaPi2b / SLC34A2 Reference Antibody (lifastuzumab vedotin)and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 0.9793 ug/mL. Human NaPi2b CHO-S Cells were stained with Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin) and negative control protein respectively, washed and then followed by PE and analyzed with FACS The drug-to-antibody ratio (DAR) of the Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin) is 3.7. The purity of Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin) is more than 95%, determined by SEC-HPLC. Anti-NaPi2b / SLC34A2 Reference Antibody (Lifastuzumab vedotin) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.